Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRK1 | P41145 | 11/20 | 0.55 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.53 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21096420 | 1.00 | OPRK1 (0.55) | OPRK1OPRM1OPRD1 | |
| SCHEMBL21097053 | 0.88 | OPRK1 (0.44) | OPRK1OPRM1OPRD1 | |
| SCHEMBL29313041 | 0.84 | ALDH1A1 (0.46) | OPRK1OPRM1OPRD1 | |
| SCHEMBL19861960 | 0.84 | ALDH1A1 (0.46) | OPRK1OPRM1OPRD1 | |
| SCHEMBL30162392 | 0.82 | CYP3A4 (0.46) | OPRK1OPRM1OPRD1 | |
| SCHEMBL18072580 | 0.81 | TACR1 (0.49) | OPRK1OPRM1OPRD1 | |
| SCHEMBL27406548 | 0.81 | SLC7A5 (0.50) | — | |
| SCHEMBL14617681 | 0.81 | SLC7A5 (0.48) | — | |
| SCHEMBL25021582 | 0.81 | OPRK1 (0.41) | OPRK1OPRM1OPRD1 | |
| SCHEMBL27406568 | 0.81 | ALDH1A1 (0.49) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3800192-A1 | PROCESSES FOR PREPARING PHARMACEUTICALLY RELEVANT PEPTIDES | Stealth Biotherapeutics Corp (MC) | 2021-04-07 | — | — | EP | disclosed |
| EP-3265109-B1 | PROCESSES FOR PREPARING PHARMACEUTICALLY RELEVANT PEPTIDES | STEALTH BIOTHERAPEUTICS CORP (MC) | 2020-10-21 | — | — | EP | disclosed |
| US-10633415-B2 | Processes for preparing pharmaceutically relevant peptides | STEALTH BIOTHERAPEUTICS CORP (MC) | 2020-04-28 | — | — | US | disclosed |
| US-20180044378-A1 | PROCESSES FOR PREPARING PHARMACEUTICALLY RELEVANT PEPTIDES | STEALTH BIOTHERAPEUTICS INC. | 2018-02-15 | — | — | US | disclosed |
| US-20180044378-A1 | PROCESSES FOR PREPARING PHARMACEUTICALLY RELEVANT PEPTIDES | STEALTH BIOTHERAPEUTICS INC. | 2018-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180044378-A1 | PROCESSES FOR PREPARING PHARMACEUTICALLY RELEVANT PEPTIDES | ADM2, VIP, PEPD | OPRK1 2236/4885OPRM1 1092/4885OPRD1 1708/4885 |
| US-10633415-B2 | Processes for preparing pharmaceutically relevant peptides | ADM2, VIP, PEPD | OPRK1 2236/4885OPRM1 1092/4885OPRD1 1708/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.